Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
54.4M
-
Number of holders
-
22
-
Total 13F shares, excl. options
-
15.1M
-
Shares change
-
-2.38M
-
Total reported value, excl. options
-
$45.7M
-
Value change
-
-$21.6M
-
Number of buys
-
11
-
Number of sells
-
-29
-
Price
-
$3.02
Significant Holders of CLIMB BIO, INC. - Common Stock, par value $0.0001 per share (CLYM) as of Q2 2022
43 filings reported holding CLYM - CLIMB BIO, INC. - Common Stock, par value $0.0001 per share as of Q2 2022.
CLIMB BIO, INC. - Common Stock, par value $0.0001 per share (CLYM) has 22 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 15.1M shares
of 54.4M outstanding shares and own 27.81% of the company stock.
Largest 10 shareholders include RA CAPITAL MANAGEMENT, L.P. (13.2M shares), SILVERARC CAPITAL MANAGEMENT, LLC (713K shares), Woodline Partners LP (373K shares), VANGUARD GROUP INC (274K shares), GOLDMAN SACHS GROUP INC (163K shares), MILLENNIUM MANAGEMENT LLC (89.9K shares), Parkwood LLC (67.2K shares), GEODE CAPITAL MANAGEMENT, LLC (64.1K shares), BlackRock Inc. (32.3K shares), and Tudor Investment Corp Et Al (30.6K shares).
This table shows the top 22 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.